Quick Takeaways
- Highpoint Pharmaceuticals LLC has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $489,028.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Highpoint Pharmaceuticals LLC
- Location
- Lewes, DE
- Summary
- The estimated value of insider holdings of Highpoint Pharmaceuticals LLC is at least $489,028 dollars as of 11 Jan 2022. Highpoint Pharmaceuticals LLC is the 10%+ Owner of Hillstream BioPharma Inc. and owns shares of Canton Strategic Holdings, Inc. (CNTN) stock worth about $489K.
- Signature
- /s/ Sireesh Appajosyula
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Highpoint Pharmaceuticals LLC and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Hillstream BioPharma Inc. ($489,028).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Highpoint Pharmaceuticals LLC
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CNTN | Hillstream BioPharma Inc. | 10%+ Owner | $489,028 | 11 Jan 2022 |
Insider Transactions Reported by Highpoint Pharmaceuticals LLC:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.